Home/ Stocks/ ATRA

Atara Biotherapeutics, Inc

ATRA XNAS

$8.54 -0.23 (-2.62%) ▼ 15-min delayed

Open

$8.60

High

$8.98

Low

$8.38

Volume

32.5K

Market Cap

$79.02M

About Atara Biotherapeutics, Inc

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$516.0K	$-4,145,000	$-0.29
FY 2025	$120.77M	$32.69M	$2.61
Q3 2025	$3.45M	$-4,303,000	$-0.32
Q2 2025	$17.57M	$2.39M	$0.20

TickerDaily Coverage

Why Is Atara Biotherapeutics (ATRA) Stock Up 56.0% Today?

Market News David Brooks · May 7, 2026

Atara Biotherapeutics (ATRA) stock ripped 56.0% higher to $8.0689 on Thursday, May 7, 2026, as...

View All Coverage →

Get ATRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Atara Biotherapeutics, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.